Advertisement
Journal of Clinical Oncology  
Search for:
Limit by:
  Browse by Subject or Issue
Home Search or Browse JCO My JCO Subscriptions Customer Service Site Map

This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Save to my personal folders
Right arrow Download to citation manager
Right arrowRights & Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tepper, J. E.
Right arrow Articles by Martenson, J. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tepper, J. E.
Right arrow Articles by Martenson, J. A.

Journal of Clinical Oncology, Vol 15, 2030-2039, Copyright © 1997 by American Society of Clinical Oncology

ARTICLES

Adjuvant postoperative fluorouracil-modulated chemotherapy combined with pelvic radiation therapy for rectal cancer: initial results of intergroup 0114

JE Tepper, MJ O'Connell, GR Petroni, D Hollis, E Cooke, AB Benson 3rd, B Cummings, LL Gunderson, JS Macdonald and JA Martenson
Department of Radiation Oncology, University of North Carolina at Chapel Hill, School of Medicine 27599-7512, USA. tepper@radonc.unc.edu

PURPOSE: The combination of radiation therapy with fluorouracil (5-FU)- based chemotherapy is generally accepted as appropriate postoperative therapy for patients with adenocarcinomas of the rectum that extend through the bowel wall or with lymph nodes positive for tumor. We attempted to determine whether the efficacy of this postoperative therapy could be improved by the addition of leucovorin and/or levamisole. METHODS: A total of 1,696 patients were randomized and eligible for treatment with one of four treatment schemes. All patients received two cycles of bolus 5-FU-based systemic chemotherapy followed by pelvic radiation therapy with chemotherapy and two more cycles of the same systemic chemotherapy. Chemotherapy was either 5-FU alone, 5- FU with leucovorin, 5-FU with levamisole, or 5-FU with leucovorin and levamisole. RESULTS: With a median follow-up duration of 48 months, there is no statistically significant advantage to any of the treatment regimens compared with bolus 5-FU alone. There is evidence of increased gastrointestinal toxicity with the three-drug combination compared with bolus 5-FU alone. Statistical analysis suggests it is very unlikely that either levamisole-containing combination will be shown to be of value with further follow-up evaluation. CONCLUSION: There is no evidence at present for a beneficial effect of levamisole in the adjuvant treatment of rectal cancer. Definitive evaluation of the effect of the addition of leucovorin to 5-FU and pelvic radiation will require further follow-up evaluation.


This article has been cited by other articles:


Home page
 Ann. Surg. Oncol.Home page
C. G. Willett and B. G. Czito
Impact of Time Duration After Neoadjuvant Therapy to Surgery on Response and Outcome in Rectal Cancer Patients
Ann. Surg. Oncol., October 1, 2008; 15(10): 2636 - 2638.
[Full Text] [PDF]

Home page
 Ann. Surg. Oncol.Home page
I. J. Park, H. C. Kim, C. S. Yu, T. W. Kim, S. J. Jang, and J. C. Kim
Effect of Adjuvant Radiotherapy on Local Recurrence in Stage II Rectal Cancer
Ann. Surg. Oncol., February 1, 2008; 15(2): 519 - 525.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
C. G. Willett, B. G. Czito, and J. C. Bendell
Radiation Therapy in Stage II and III Rectal Cancer
Clin. Cancer Res., November 15, 2007; 13(22): 6903s - 6908s.
[Abstract] [Full Text] [PDF]

Home page
 CA Cancer J ClinHome page
B. M. Wolpin, J. A. Meyerhardt, H. J. Mamon, and R. J. Mayer
Adjuvant Treatment of Colorectal Cancer
CA Cancer J Clin, May 1, 2007; 57(3): 168 - 185.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
P. G. Johnston
Prognostic Markers of Local Relapse in Rectal Cancer: Are We Any Further Forward?
J. Clin. Oncol., September 1, 2006; 24(25): 4049 - 4050.
[Full Text] [PDF]

Home page
 JCOHome page
S. R. Smalley, J. K. Benedetti, S. K. Williamson, J. M. Robertson, N. C. Estes, T. Maher, B. Fisher, T. A. Rich, J. A. Martenson, J. W. Kugler, et al.
Phase III Trial of Fluorouracil-Based Chemotherapy Regimens Plus Radiotherapy in Postoperative Adjuvant Rectal Cancer: GI INT 0144
J. Clin. Oncol., August 1, 2006; 24(22): 3542 - 3547.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Surg. Oncol.Home page
D. K. Monga and M. J. O'Connell
Surgical Adjuvant Therapy for Colorectal Cancer: Current Approaches and Future Directions
Ann. Surg. Oncol., August 1, 2006; 13(8): 1021 - 1034.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
C. H. Crane and D. J. Sargent
Substitution of Oral Fluoropyrimidines for Infusional Fluorouracil With Radiotherapy: How Much Data Do We Need?
J. Clin. Oncol., August 1, 2004; 22(15): 2978 - 2981.
[Full Text] [PDF]

Home page
 JCOHome page
C. Fernandez-Martos, J. Aparicio, C. Bosch, M. Torregrosa, J. M. Campos, S. Garcera, J. M. Vicent, I. Maestu, M. A. Climent, J. L. Mengual, et al.
Preoperative Uracil, Tegafur, and Concomitant Radiotherapy in Operable Rectal Cancer: A Phase II Multicenter Study With 3 Years' Follow-Up
J. Clin. Oncol., August 1, 2004; 22(15): 3016 - 3022.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
L. L. Gunderson, D. J. Sargent, J. E. Tepper, N. Wolmark, M. J. O'Connell, M. Begovic, C. Allmer, L. Colangelo, S. R. Smalley, D. G. Haller, et al.
Impact of T and N Stage and Treatment on Survival and Relapse in Adjuvant Rectal Cancer: A Pooled Analysis
J. Clin. Oncol., May 15, 2004; 22(10): 1785 - 1796.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
J. A. Meyerhardt, J. E. Tepper, D. Niedzwiecki, D. R. Hollis, A. D. McCollum, D. Brady, M. J. O'Connell, R. J. Mayer, B. Cummings, C. Willett, et al.
Impact of Body Mass Index on Outcomes and Treatment-Related Toxicity in Patients With Stage II and III Rectal Cancer: Findings From Intergroup Trial 0114
J. Clin. Oncol., February 15, 2004; 22(4): 648 - 657.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
J. A. Meyerhardt, J. E. Tepper, D. Niedzwiecki, D. R. Hollis, D. Schrag, J. Z. Ayanian, M. J. O'Connell, J. C. Weeks, R. J. Mayer, C. G. Willett, et al.
Impact of Hospital Procedure Volume on Surgical Operation and Long-Term Outcomes in High-Risk Curatively Resected Rectal Cancer: Findings From the Intergroup 0114 Study
J. Clin. Oncol., January 1, 2004; 22(1): 166 - 174.
[Abstract] [Full Text] [PDF]

Home page
 Ann OncolHome page
R. Gray, R. Hills, and R. Stowe
Anything in modulation?
Ann. Onc., September 1, 2003; 14(9): 1338 - 1339.
[Full Text] [PDF]

Home page
 Ann OncolHome page
F. Di Costanzo, A. Sobrero, S. Gasperoni, L. Dogliotti, L. Frassineti, A. Falcone, R. Lionetto, P. Bruzzi, G. Luppi, L. Gallo, et al.
Adjuvant chemotherapy in the treatment of colon cancer: randomized multicenter trial of the Italian National Intergroup of Adjuvant Chemotherapy in Colon Cancer (INTACC)
Ann. Onc., September 1, 2003; 14(9): 1365 - 1372.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
J. Dunst, T. Reese, T. Sutter, H. Zuhlke, A. Hinke, K. Kolling-Schlebusch, and S. Frings
Phase I Trial Evaluating the Concurrent Combination of Radiotherapy and Capecitabine in Rectal Cancer
J. Clin. Oncol., October 1, 2002; 20(19): 3983 - 3991.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
H. M. Moulton, P. H. Yoshihara, D. H. Mason, P. L. Iversen, and P. L. Triozzi
Active Specific Immunotherapy with a {beta}-Human Chorionic Gonadotropin Peptide Vaccine in Patients with Metastatic Colorectal Cancer: Antibody Response Is Associated with Improved Survival
Clin. Cancer Res., July 1, 2002; 8(7): 2044 - 2051.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
A. I. Neugut, A. T. Fleischauer, V. Sundararajan, N. Mitra, D. F. Heitjan, J. S. Jacobson, and V. R. Grann
Use of Adjuvant Chemotherapy and Radiation Therapy for Rectal Cancer Among the Elderly: A Population-Based Study
J. Clin. Oncol., June 1, 2002; 20(11): 2643 - 2650.
[Abstract] [Full Text] [PDF]

Home page
 Ann OncolHome page
J. Feliu, J. Calvillo, A. Escribano, J. de Castro, M. E. Sanchez, A. Mata, E. Espinosa, A. Garcia Grande, A. Mateo, and M. Gonzalez Baron
Neoadjuvant therapy of rectal carcinoma with UFT-leucovorin plus radiotherapy
Ann. Onc., May 1, 2002; 13(5): 730 - 736.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
J.E. Tepper, M. O'Connell, D. Niedzwiecki, D.R. Hollis, A.B. Benson III, B. Cummings, L.L. Gunderson, J.S. Macdonald, J.A. Martenson, and R.J. Mayer
Adjuvant Therapy in Rectal Cancer: Analysis of Stage, Sex, and Local Control--Final Report of Intergroup 0114
J. Clin. Oncol., April 1, 2002; 20(7): 1744 - 1750.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
J.-H. Lee, J.-H. Lee, J.-H. Ahn, H. Bahng, T.-W. Kim, Y.-K. Kang, K.-H. Lee, J.-C. Kim, C.-S. Yu, J.-H. Kim, et al.
Randomized Trial of Postoperative Adjuvant Therapy in Stage II and III Rectal Cancer to Define the Optimal Sequence of Chemotherapy and Radiotherapy: A Preliminary Report
J. Clin. Oncol., April 1, 2002; 20(7): 1751 - 1758.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
L. Stocchi, H. Nelson, D. J. Sargent, M. J. O'Connell, J. E. Tepper, J. E. Krook, and R. Beart Jr
Impact of Surgical and Pathologic Variables in Rectal Cancer: A United States Community and Cooperative Group Report
J. Clin. Oncol., September 15, 2001; 19(18): 3895 - 3902.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
J. S. Macdonald, S. R. Smalley, J. Benedetti, S. A. Hundahl, N. C. Estes, G. N. Stemmermann, D. G. Haller, J. A. Ajani, L. L. Gunderson, J. M. Jessup, et al.
Chemoradiotherapy after Surgery Compared with Surgery Alone for Adenocarcinoma of the Stomach or Gastroesophageal Junction
N. Engl. J. Med., September 6, 2001; 345(10): 725 - 730.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
J. E. Tepper, M. J. O'Connell, D. Niedzwiecki, D. Hollis, C. Compton, A. B. Benson III, B. Cummings, L. Gunderson, J. S. Macdonald, and R. J. Mayer
Impact of Number of Nodes Retrieved on Outcome in Patients With Rectal Cancer
J. Clin. Oncol., January 1, 2001; 19(1): 157 - 163.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
P. M. Hoff, N. Janjan, E. D. Saad, J. Skibber, C. Crane, Y. Lassere, K. R. Cleary, S. Benner, J. Randolph, J. L. Abbruzzese, et al.
Phase I Study of Preoperative Oral Uracil and Tegafur Plus Leucovorin and Radiation Therapy in Rectal Cancer
J. Clin. Oncol., October 20, 2000; 18(20): 3529 - 3534.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
A. B. Benson III, C. E. Desch, P. J. Flynn, C. Krause, C. L. Loprinzi, B. D. Minsky, N. J. Petrelli, D. G. Pfister, T. J. Smith, and M. R. Somerfield
2000 Update of American Society of Clinical Oncology Colorectal Cancer Surveillance Guidelines
J. Clin. Oncol., October 20, 2000; 18(20): 3586 - 3588.
[Full Text] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
N. Wolmark, H. S. Wieand, D. M. Hyams, L. Colangelo, N. V. Dimitrov, E. H. Romond, M. Wexler, D. Prager, A. B. Cruz Jr., P. H. Gordon, et al.
Randomized Trial of Postoperative Adjuvant Chemotherapy With or Without Radiotherapy for Carcinoma of the Rectum: National Surgical Adjuvant Breast and Bowel Project Protocol R-02
J Natl Cancer Inst, March 1, 2000; 92(5): 388 - 396.
[Abstract] [Full Text] [PDF]


About
JCO		 Editorial
Roster		 Advertising
Information		 Librarians &
Institutions		 Rights &
Permissions		 PDA Services

Copyright © 1997 by the American Society of Clinical Oncology, Online ISSN: 1527-7755. Print ISSN: 0732-183X
Terms and Conditions of Use
  HighWire Press HighWire Press™ assists in the publication of JCO Online